Contact this trialFirst, we need to learn more about you.
AZD4831 for NASH with Fibrosis
Recruiting0 awardsPhase 2
Yonkers, New York
This trial is testing a new drug to treat NASH, with participants monitored for up to 22 weeks. They won't benefit but will help researchers learn more.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.